全文获取类型
收费全文 | 2375124篇 |
免费 | 194645篇 |
国内免费 | 4209篇 |
专业分类
耳鼻咽喉 | 34264篇 |
儿科学 | 72749篇 |
妇产科学 | 62928篇 |
基础医学 | 334899篇 |
口腔科学 | 67524篇 |
临床医学 | 215520篇 |
内科学 | 468583篇 |
皮肤病学 | 47939篇 |
神经病学 | 200804篇 |
特种医学 | 95960篇 |
外国民族医学 | 886篇 |
外科学 | 360391篇 |
综合类 | 56219篇 |
现状与发展 | 1篇 |
一般理论 | 977篇 |
预防医学 | 190600篇 |
眼科学 | 55463篇 |
药学 | 177527篇 |
4篇 | |
中国医学 | 4365篇 |
肿瘤学 | 126375篇 |
出版年
2018年 | 24205篇 |
2016年 | 20575篇 |
2015年 | 23279篇 |
2014年 | 33535篇 |
2013年 | 50829篇 |
2012年 | 68738篇 |
2011年 | 72276篇 |
2010年 | 42473篇 |
2009年 | 40862篇 |
2008年 | 68762篇 |
2007年 | 73097篇 |
2006年 | 73999篇 |
2005年 | 72039篇 |
2004年 | 69334篇 |
2003年 | 67017篇 |
2002年 | 66259篇 |
2001年 | 112453篇 |
2000年 | 116528篇 |
1999年 | 98335篇 |
1998年 | 27858篇 |
1997年 | 25523篇 |
1996年 | 25448篇 |
1995年 | 24609篇 |
1994年 | 23162篇 |
1993年 | 21553篇 |
1992年 | 79389篇 |
1991年 | 76393篇 |
1990年 | 73579篇 |
1989年 | 70845篇 |
1988年 | 65851篇 |
1987年 | 64805篇 |
1986年 | 61340篇 |
1985年 | 58402篇 |
1984年 | 44224篇 |
1983年 | 37657篇 |
1982年 | 22887篇 |
1981年 | 20332篇 |
1980年 | 19037篇 |
1979年 | 41307篇 |
1978年 | 28987篇 |
1977年 | 24348篇 |
1976年 | 22832篇 |
1975年 | 23965篇 |
1974年 | 29638篇 |
1973年 | 28045篇 |
1972年 | 26227篇 |
1971年 | 24153篇 |
1970年 | 22754篇 |
1969年 | 21088篇 |
1968年 | 19136篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
41.
N. S. Hari Narayana Moorthy Sergio F. Sousa Maria J. Ramos Pedro A. Fernandes 《Medicinal chemistry research》2016,25(7):1340-1357
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets. 相似文献
42.
43.
44.
45.
Elizabeth M. Broad Laura J. Newsome Dustin A. Dew 《The journal of spinal cord medicine》2020,43(3):388-397
Objective: Report measured resting energy expenditure (REE) in wheelchair rugby athletes and evaluate agreement between REE and the prediction models of Chun, Cunningham, Harris-Benedict, Mifflin, Nightingale and Gorgey, and Owen.Design: Cohort-based validation study.Setting. Paralympic team training camp.Participants: Fourteen internationally competitive athletes who play wheelchair rugby, 13 of whom had cervical spinal cord injuries (SCI).Outcome Measures: A portable metabolic analyzer was used to measure REE following an overnight fast and dual-energy X-ray absorptiometry (DXA) was used to assess lean body mass for the prediction equations.Results: REE in the current sample was 1735?±?257?kcal?×?day?1 ranging from 1324 to 2068?kcal?×?day?1. Bland–Altman analyses revealed negative mean bias but similar limits of agreement between measured REE and scores predicted by Chun, Cunningham, Mifflin, Nightingale and Gorgey, and Owen models in elite athletes who play wheelchair rugby.Conclusion: Prediction models regressed on persons with and without SCI under-predicted REE of competitive wheelchair rugby athletes. This outcome may be explained by the higher REE/fat-free mass (FFM) ratio of current athletes compared to less active samples. Findings from the current study will help practitioners to determine nutrient intake needs on training days of varied intensity. 相似文献
46.
47.
Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep 下载免费PDF全文
Flavio Torres Alejandro González‐Candia Camilo Montt Germán Ebensperger Magdalena Chubretovic María Serón‐Ferré Roberto V. Reyes Aníbal J. Llanos Emilio A. Herrera 《Journal of pineal research》2015,58(3):362-373
Pulmonary hypertension of the newborn (PHN) constitutes a critical condition with severe cardiovascular and neurological consequences. One of its main causes is hypoxia during gestation, and thus, it is a public health concern in populations living above 2500 m. Although some mechanisms are recognized, the pathophysiological facts that lead to PHN are not fully understood, which explains the lack of an effective treatment. Oxidative stress is one of the proposed mechanisms inducing pulmonary vascular dysfunction and PHN. Therefore, we assessed whether melatonin, a potent antioxidant, improves pulmonary vascular function. Twelve newborn sheep were gestated, born, and raised at 3600 meters. At 3 days old, lambs were catheterized and daily cardiovascular measurements were recorded. Lambs were divided into two groups, one received daily vehicle as control and another received daily melatonin (1 mg/kg/d), for 8 days. At 11 days old, lung tissue and small pulmonary arteries (SPA) were collected. Melatonin decreased pulmonary pressure and resistance for the first 3 days of treatment. Further, melatonin significantly improved the vasodilator function of SPA, enhancing the endothelial‐ and muscular‐dependent pathways. This was associated with an enhanced nitric oxide‐dependent and nitric oxide independent vasodilator components and with increased nitric oxide bioavailability in lung tissue. Further, melatonin reduced the pulmonary oxidative stress markers and increased enzymatic and nonenzymatic antioxidant capacity. Finally, these effects were associated with an increase of lumen diameter and a mild decrease in the wall of the pulmonary arteries. These outcomes support the use of melatonin as an adjuvant in the treatment for PHN. 相似文献
48.
49.
50.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers 下载免费PDF全文